Results 31 to 40 of about 165,068 (304)

A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...
Yuh‐Shan Ho   +7 more
wiley   +1 more source

Access to pharmaceutical professional services: motivations, preferences, barriers, knowledge, and use of ICT among patients in Antioquia

open access: yesMedicina U.P.B.
Objective: To identify patients’ knowledge and needs regarding pharmaceutical care services in drugstores, pharmacies-drugstores, and outpatient pharmaceutical services in Antioquia, Colombia.Methods: A descriptive cross-sectional study was conducted ...
Raquel Agudelo Guisao   +4 more
doaj   +1 more source

An isoform of 14‐3‐3 protein regulates transbilayer lipid movement at the plasma membrane

open access: yesFEBS Letters, EarlyView.
Loss of 14‐3‐3ζ in CHO cells confers resistance to exogenous phosphatidylserine (PS) and impairs endocytosis‐independent inward flip‐flop of fluorescent PS at the plasma membrane. RNAi‐mediated knockdown reproduces this defect, while no additive effect is seen in ATP11C‐deficient cells.
Akiko Yamaji‐Hasegawa   +3 more
wiley   +1 more source

Making the investment case for national regulatory authorities

open access: yesJournal of Pharmaceutical Policy and Practice, 2021
Well-functioning national regulatory authorities (NRAs) ensure access to safe, effective, quality-assured, and affordable medical products. However, the benefits of their work are often unseen and difficult to attribute, thereby making NRAs undervalued ...
Gloria Twesigye   +2 more
doaj   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Artificial intelligence accelerates drug discovery and enhances commercialization efficiency

open access: yesDiscover Artificial Intelligence
Artificial Intelligence has enriched drug Discovery and development, making it faster and easier. This Review article summarizes the use of AI across various stages of drug discovery and development, as well as in marketing and commercialization. It also
Vrushab Sunil Pipada   +5 more
doaj   +1 more source

Elderly People and Digital Pharmaceutical Services: Challenges, Needs and Solutions

open access: yesРоссийский журнал гериатрической медицины
In the context of global population aging, ensuring the availability and quality of healthcare services for the elderly is becoming relevant. Digital healthcare, including pharmaceutical services, opens up new opportunities to improve their quality of ...
Yu. A. Lisenkova, I. A. Grigorieva
doaj   +1 more source

The relationship of pharmaceutical services toward the use of herbal medicine : Indonesian case

open access: yesJurnal Profesi Medika, 2020
Pharmaceutical services are services provided by a pharmacist in providing health information including the use of herbal medicines. The purpose of this study was to look at the relationship between pharmaceutical services and the use of herbal medicines
Putu Eka Arimbawa   +3 more
doaj   +1 more source

Establishing an assay to evaluate d‐amino acid oxidase enzyme kinetics and inhibition using WST‐8 redox dye

open access: yesFEBS Open Bio, EarlyView.
This study investigated a novel WST‐8‐based assay for evaluating d‐Amino acid oxidase (DAO) inhibitors. We confirmed its effectiveness using known inhibitors and found that uremic toxins possess relatively weak inhibitory activity compared to existing drugs.
Kahoko Miyake   +4 more
wiley   +1 more source

Pharmaceutical care in smoking cessation

open access: yes, 2015
Alicia Marín Armero,1 Miguel A Calleja Hernandez,2 Sabina Perez-Vicente,3 Fernando Martinez-Martinez4 1Community Pharmacy, Murcia, Spain; 2Hospital Pharmacy, University Hospital Virgen de las Nieves, Granada, Spain; 3Result Evaluation Unit ...
Perez-Vicente, Sabina   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy